Literature DB >> 20563759

Thrombolysis for indwelling catheter related thrombosis and superior vena cava obstruction in cystic fibrosis: a case series.

T Hassan, S H Chotirmall, T B Low, M G Flynn, N G McElvaney, C Gunaratnam.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20563759     DOI： 10.1007/s11845-010-0488-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  11 in total

1.  Totally implantable vascular access in treatment of cystic fibrosis.

Authors:  J Pattison; D P Heaf
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

2.  Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis.

Authors:  Michael Barker; Daniel Thoenes; Hiltrud Döhmen; Frank Friedrichs; Claus Pfannenstiel; Gerhard Heimann
Journal:  Pediatr Pulmonol       Date:  2005-02

3.  Thrombophilia in children with cystic fibrosis.

Authors:  I M Balfour-Lynn; K Malbon; J F Burman; S J Davidson
Journal:  Pediatr Pulmonol       Date:  2005-04

Review 4.  Superior vena cava syndrome related to indwelling intravenous catheters in patients with cystic fibrosis.

Authors:  Susan Garwood; Patrick A Flume; James Ravenel
Journal:  Pediatr Pulmonol       Date:  2006-07

5.  Thrombin generation by exposure of blood to endotoxin: a simple model to study disseminated intravascular coagulation.

Authors:  T W Stief
Journal:  Clin Appl Thromb Hemost       Date:  2006-04       Impact factor: 2.389

Review 6.  Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.

Authors:  Melina Verso; Giancarlo Agnelli
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

7.  Thrombolytic therapy for management of complicated catheter-related Candida albicans thrombophlebitis.

Authors:  A A Block; K A Thursky; L J Worth; M A Slavin
Journal:  Intern Med J       Date:  2009-01       Impact factor: 2.048

8.  Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease.

Authors:  Manju Kalra; Peter Gloviczki; James C Andrews; Kenneth J Cherry; Thomas C Bower; Jean M Panneton; Haraldur Bjarnason; Audra A Noel; Cathy Schleck; William S Harmsen; Linda G Canton; Peter C Pairolero
Journal:  J Vasc Surg       Date:  2003-08       Impact factor: 4.268

9.  Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.

Authors:  J Deerojanawong; S M Sawyer; A M Fink; K B Stokes; C F Robertson
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

Review 10.  Diagnosis and management of superior vena cava syndrome.

Authors:  M Markman
Journal:  Cleve Clin J Med       Date:  1999-01       Impact factor: 2.321
View more
  2 in total

1.  Risk factors for totally implantable venous access device-associated complications in cystic fibrosis.

Authors:  C McCarthy; O O'Carroll; M E O'Brien; T McEnery; A Franciosi; C Gunaratnam; N G McElvaney
Journal:  Ir J Med Sci       Date:  2017-08-15       Impact factor: 1.568

Review 2.  Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.

Authors:  James F Chmiel; Timothy R Aksamit; Sanjay H Chotirmall; Elliott C Dasenbrook; J Stuart Elborn; John J LiPuma; Sarath C Ranganathan; Valerie J Waters; Felix A Ratjen
Journal:  Ann Am Thorac Soc       Date:  2014-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.